SU1424807A1 - Method of determining indications to surgical treatment of inner endometriosis of uterus - Google Patents
Method of determining indications to surgical treatment of inner endometriosis of uterus Download PDFInfo
- Publication number
- SU1424807A1 SU1424807A1 SU864092309A SU4092309A SU1424807A1 SU 1424807 A1 SU1424807 A1 SU 1424807A1 SU 864092309 A SU864092309 A SU 864092309A SU 4092309 A SU4092309 A SU 4092309A SU 1424807 A1 SU1424807 A1 SU 1424807A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- uterus
- surgical treatment
- endometriosis
- treatment
- determining indications
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 6
- 238000001356 surgical procedure Methods 0.000 title claims abstract description 6
- 208000005641 Adenomyosis Diseases 0.000 title 1
- 201000009274 endometriosis of uterus Diseases 0.000 title 1
- 210000004185 liver Anatomy 0.000 claims abstract description 6
- 229940121896 radiopharmaceutical Drugs 0.000 claims abstract description 5
- 239000012217 radiopharmaceutical Substances 0.000 claims abstract description 5
- 230000002799 radiopharmaceutical effect Effects 0.000 claims abstract description 5
- 201000009273 Endometriosis Diseases 0.000 claims abstract description 4
- 210000000232 gallbladder Anatomy 0.000 claims abstract description 4
- 210000004291 uterus Anatomy 0.000 claims description 4
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
- A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
- A61B6/4258—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Изобретение относитс к медицине, точнее к гинекологии. Цель изобретени - повышение точности способа. Дл этого больным перед назначением лечени провод т динамическую сцинтиграфию печени с при- .менением радиофармпрепарата Тс и при увеличении периода полувыведени (T|/2) до 58-|-2 мин и уменьшении процента выведени РФП из желчного пузыр в кишечник (Ка) до 11+3% назначают хирургическое лечение. Предлагаемый способ позвол ет повысить точность лечени больных эндометриозом матки на 48%.The invention relates to medicine, more specifically to gynecology. The purpose of the invention is to improve the accuracy of the method. For this, patients are given a dynamic scintigraphy of the liver with the use of Tc radiopharmaceutical before prescribing treatment and increasing the half-life (T | / 2) to 58- | -2 minutes and reducing the percentage of radiopharmaceuticals from the gallbladder to the intestine (Ka) to 11 + 3% prescribe surgical treatment. The proposed method allows to increase the accuracy of treatment of patients with uterine endometriosis by 48%.
Description
4;four;
юYu
4four
СХ)CX)
li - oopcTCiine oTfificii i i ji к опласти модиJilllib , :. именно 1Ч111С-К().1ОГИИ.li - oopcTCiine oTfificii i i ji to the mod jilllib,:. 1CH111C-K (). 1OGIs.
ЦчМ)К) изобретени вл етс повышение | :}Ч|()ети способа.CCM) K) of the invention is an increase | :} W | () this way.
Способ осуществл етс следующим образом .The method is carried out as follows.
Больным перед назначением лечени провод т динамическую сцинтиграфию печени с применением радиофармпрепарата Tt и при увеличении периода полувыведени (Ti/2) до 58+2 мин и уменьшении процента выведени РФП из желчного пузыр в кищечник (К2) до П+З назначают хирургическое лечение.Before treatment, patients undergo dynamic liver scintigraphy using Tt radiopharmaceuticals and increase the half-life (Ti / 2) to 58 + 2 minutes and decrease the percentage of radiopharmaceuticals from the gallbladder to the intestine (K2) to P + C and prescribe a surgical treatment.
При периоде полувыведени 34-|-1,3 мин и Kg 68-f-l,2% назначают консервативное лечение.With a half-life of 34- | -1.3 min and Kg 68-f-1, 2% prescribed conservative treatment.
Пример 1. Больна А. Поступила с жалобами па посто нные боли внизу живота, усиливающиес при менструации, почти непрекращающиес мажущие выделени из половых путей. Перенесенные заболевани - корь, скарлатина. Менструации с 14 лет, болезненные последние 2 года, обильные, мажущие выделени за 5 дней до менструации . Полова жипь в течение 2 лет, беременностей не было, не предохран лась. Диагноз - эндометриоз матки 1 степени распространени . Проведена динамическа сцинтиграфи печени и установлено, что Т|/2 34 мин, К2 66%. Проведено лечение нон-овлоном в течение года. Через 9 мес у пациентки отмечалось улучщение общего состо ни , нормализаци менструальнойExample 1. Patient A. Conducted with complaints of persistent abdominal pain, aggravated during menstruation, an almost uninterrupted spreading discharge from the genital tract. Transferred diseases - measles, scarlet fever. Menstruation from the age of 14, painful last 2 years, copious, spotting 5 days before the menstruation. Gypsum sex during 2 years, there were no pregnancies, it was not protected. The diagnosis is endometriosis of the uterus of the first degree. Dynamic scintigraphy of the liver was carried out and it was established that T | / 2 34 min, K2 66%. A non-levy treatment was carried out for a year. After 9 months, the patient showed improvement in the general condition, normalization of the menstrual period.
функции, исчезновение болей, атрофи эн- дометриоидных очагов.function, the disappearance of pain, atrophy endometrioid foci.
Пример 2. Больна В. Поступила с жалобами на резкие боли во врем менструации , боли при дефекации, длительные кров нистые выделени до начала менструации . За год до обращени в клинику проведено безуспещное лечение эстро- генгестагенными препаратами. При обследовании установлен диагноз - эндометриозExample 2. Patient B. Received complaints of sharp pain during menstruation, pain during defecation, prolonged bleeding before menstruation. A year before going to the clinic, successful treatment with estrogen progestin preparations was performed. During the examination, the diagnosis - endometriosis
матки И-III степени распространени . При динамической сцинтиграфии печени вы влено увеличение Ti« до 60 мин, уменьще- ние К2 до 14%. Больной произведена операци - надвлагалищна ампутаци матки без придатков, учитыва диффузный характер распространени . После операции пациентка жалоб не предъ вл ла, рецидива заболевани не наблюдалось, через год нормализовалась поглотительно-выделительна функци печени и желчногоuterus I-III degree of distribution. With dynamic liver scintigraphy, an increase in Ti was found up to 60 minutes, a decrease in K2 to 14%. The patient underwent surgery - supravaginal amputation of the uterus without appendages, taking into account the diffuse nature of the distribution. After the operation, the patient did not complain, there was no recurrence of the disease, after a year the absorption and excretory function of the liver and gall bladder normalized.
пузыр .bubble
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU864092309A SU1424807A1 (en) | 1986-07-14 | 1986-07-14 | Method of determining indications to surgical treatment of inner endometriosis of uterus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU864092309A SU1424807A1 (en) | 1986-07-14 | 1986-07-14 | Method of determining indications to surgical treatment of inner endometriosis of uterus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1424807A1 true SU1424807A1 (en) | 1988-09-23 |
Family
ID=21247028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU864092309A SU1424807A1 (en) | 1986-07-14 | 1986-07-14 | Method of determining indications to surgical treatment of inner endometriosis of uterus |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1424807A1 (en) |
-
1986
- 1986-07-14 SU SU864092309A patent/SU1424807A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Железнов Б. И., Стрижаков А. Н. Ге- нитальный эндо.метриоз. М.: Медицина, 1985, с. 36. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rice-Wray et al. | Long-term administration of norethindrone in fertility control | |
| LT4072B (en) | Use of a cross-linked polycarboxylic polymer and progesterone for manufacture of medicinal preparations | |
| Daniell et al. | Combined laparoscopic surgery and danazol therapy for pelvic endometriosis | |
| Mishell Jr et al. | Inhibition of ovulation with cyclic use of progestogen-impregnated intravaginal devices | |
| Ekström et al. | Effect of an oral contraceptive in primary dysmenorrhea—changes in uterine activity and reactivity to agonists | |
| Green et al. | Cretinism associated with maternal sodium iodide I 131 therapy during pregnancy | |
| Tyler | Treatment of anovulation with menotropins | |
| Rabinerson et al. | Membranous dysmenorrhea: the forgotten entity | |
| SU1424807A1 (en) | Method of determining indications to surgical treatment of inner endometriosis of uterus | |
| Johansson et al. | The effect of progestin R 2323 released from vaginal rings on ovarian function | |
| US5624670A (en) | Use of interleukin-8 for inducing cervical ripening | |
| Urry et al. | Artificial insemination: a comparison of pregnancy rates with intrauterine versus cervical insemination and washed sperm versus serum swim-up sperm preparations | |
| Kyle et al. | Giant cell arteritis of myometrial and axillary arteries and polymyalgia rheumatica. | |
| GOLDMAN et al. | Severe pneumococcal peritonitis complicating IUD: case report and review of the literature | |
| RU2000115313A (en) | GESTAGEN-ANTI-GESTAGEN RECEPTION DIAGRAMS | |
| WEILERSTEIN | Intrauterine pastes | |
| RU2108583C1 (en) | Method for determining indications to applying hormone therapy in genital endometriosis patients | |
| PALMER | The excretion of free oestrogen during uterine bleeding | |
| Csapo et al. | Menstrual induction by the vaginal application of ICI 81008 gel | |
| Fylling et al. | 15 (S) 15-Methyl protaglandin F2α for termination of very early human pregnancy. A comparative study of a single intramuscular injection and vaginal suppositories | |
| Karim et al. | Menstrual induction--termination of early pregnancy with a new prostaglandin analogue SHB 286 | |
| Bromberg et al. | Mechanism of ovulation bleeding | |
| RU2145809C1 (en) | Method and means of contragestation | |
| Pillay | Vitamin-C test for ovulation | |
| RU2160109C1 (en) | Method for treating endocrine infertility |